Similarly, RBM4 was shown to suppress tumor progression and to counter a colorectal metastatic cascade through modulation of alternative splicing (Wang et al., 2014; Lin et al., 2018), and its expression was decreased in various tumor types. Here, RBM4 is linked to neoplasm.